Therapeutic Treatment Options and Outcomes

This research area will focus on better understanding the relative efficacy and effectiveness of various therapeutic treatment options including drugs, and appropriate use of therapeutics to mitigate impact of the virus. Analysis should consider improving the supply chain for, and access to, various therapeutic treatment options.

Key Challenge Questions: 

  1. What is the relative efficacy and effectiveness of various therapeutic treatment options including therapeutic drugs and other forms of treatment?

    1. What are the factors influencing the relative efficacy and effectiveness of various therapeutic treatment options at population level?

    2. How can we improve clinical decision making regarding appropriate use of therapeutic drugs?

  2. Can we predict the ideal mix of therapeutic drugs that will be needed for purpose of planning and resource allocation? Analysis should consider expected timing and supply of various therapeutics.

  3. What is the most cost-effective approach to the use of therapeutics to mitigate population level impacts of COVID-19?
Please consider: All analyses should include consideration of population sub-groups, for example: sex, gender, and sexual orientation; people with high risk clinical characteristics; people with physical and/or mental health disabilities; Indigenous peoples and communities; immigrants and refugees; ethno-racial communities; Francophone communities; linguistic communities; religious/faith communities; homeless people; people living on a low income; people receiving social assistance; people using drugs; and people living in rural/remote or inner urban areas. 

Date modified: 2021-11-30